Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome.
Jalink M, Berentsen S, Castillo JJ, Treon SP, Cruijsen M, Fattizzo B, Cassin R, Fotiou D, Kastritis E, De Haas M, Oosten LEM, Frederiksen H, Patriarca A, D'Sa S, Vos JMI. Jalink M, et al. Among authors: kastritis e. Blood. 2021 Nov 18;138(20):2002-2005. doi: 10.1182/blood.2021012039. Blood. 2021. PMID: 34293088 Free article. No abstract available.
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.
Dimopoulos MA, Gertz MA, Kastritis E, Garcia-Sanz R, Kimby EK, Leblond V, Fermand JP, Merlini G, Morel P, Morra E, Ocio EM, Owen R, Ghobrial IM, Seymour J, Kyle RA, Treon SP. Dimopoulos MA, et al. Among authors: kastritis e. J Clin Oncol. 2009 Jan 1;27(1):120-6. doi: 10.1200/JCO.2008.17.7865. Epub 2008 Dec 1. J Clin Oncol. 2009. PMID: 19047284 Review.
When a little aspirin may be enough.
Kastritis E, Dimopoulos MA. Kastritis E, et al. Blood. 2012 Jan 26;119(4):905-6. doi: 10.1182/blood-2011-08-375089. Blood. 2012. PMID: 22282490 Free article.
VWF, WM, and angiogenesis: is there a link?
Kastritis E, Dimopoulos MA. Kastritis E, et al. Blood. 2012 Oct 18;120(16):3163-4. doi: 10.1182/blood-2012-08-451468. Blood. 2012. PMID: 23086619 Free article. No abstract available.
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN).
Dimopoulos MA, García-Sanz R, Gavriatopoulou M, Morel P, Kyrtsonis MC, Michalis E, Kartasis Z, Leleu X, Palladini G, Tedeschi A, Gika D, Merlini G, Kastritis E, Sonneveld P. Dimopoulos MA, et al. Among authors: kastritis e. Blood. 2013 Nov 7;122(19):3276-82. doi: 10.1182/blood-2013-05-503862. Epub 2013 Sep 4. Blood. 2013. PMID: 24004667 Free article. Clinical Trial.
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus.
Dimopoulos MA, Kastritis E, Owen RG, Kyle RA, Landgren O, Morra E, Leleu X, García-Sanz R, Munshi N, Anderson KC, Terpos E, Ghobrial IM, Morel P, Maloney D, Rummel M, Leblond V, Advani RH, Gertz MA, Kyriakou C, Thomas SK, Barlogie B, Gregory SA, Kimby E, Merlini G, Treon SP. Dimopoulos MA, et al. Among authors: kastritis e. Blood. 2014 Aug 28;124(9):1404-11. doi: 10.1182/blood-2014-03-565135. Epub 2014 Jul 15. Blood. 2014. PMID: 25027391 Free PMC article. Review.
Treatment options for relapsed and refractory multiple myeloma.
Nooka AK, Kastritis E, Dimopoulos MA, Lonial S. Nooka AK, et al. Among authors: kastritis e. Blood. 2015 May 14;125(20):3085-99. doi: 10.1182/blood-2014-11-568923. Epub 2015 Apr 2. Blood. 2015. PMID: 25838342 Free article. Review.
466 results